Pamela Kunz stated she left Stanford Faculty of Drugs due to years of gender-related microaggressions and verbal abuse she skilled there. She wasn’t...
The FDA has accepted pembrolizumab for the first-line therapy of sure HER2-negative gastric and gastroesophageal junction cancers.
The U.S. Meals and Drug Administration (FDA)...
